Human serum albumin (HSA) is the most abundant plasma protein and has an inherent ability to target tumor cells. It is an excellent candidate for drug delivery. However, HSA cannot form complex with DNA or RNA, because it is negatively charged under physiological conditions. In this work, we reported a simple method to prepare HSA/RNA nanoparticles mainly by physical interaction. Firstly, the solution pH is adjusted to 4.0, under which condition HSA is positively charged. It forms complex with RNA via electrostatic interaction. The solution is then heated at 75 oC for 15 min to stabilize the structure and the size of the formed complex. The HSA/RNA nanoparticle prepared by this method has a diameter about 110 nm and a narrow distribution. I...
This study investigated the interaction between Human Serum Albumin (HSA) and microRNA 155 (miR-155)...
© The Royal Society of Chemistry. Gene therapy through systemic administration is expected to offer ...
Serum albumin (SA) is the most abundant protein in plasma and represents the main carrier of endogen...
Gene regulation through small interfering RNA (siRNA) is a useful way to improve therapeutics and tr...
In recent years, cancer has become an ever-growing issue in the eyes of the public and with such att...
The development of nucleic acid therapeutics has been hampered by issues associated with their stabi...
Small interfering RNA (siRNA) is receiving increasing attention with regard to the treatment of many...
The development of nonviral gene delivery systems is a great challenge to enable safe gene therapy. ...
Cancer is one of the major health problems worldwide, and hence, suitable therapies with enhanced ef...
For systemic siRNA delivery applications, well-defined drug carriers are required that guarantee sta...
Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, Arun Kulamarva, Satya PrakashBiomedical Technology ...
In this article, we address the design of innovative human serum albumin (HSA)-based nanoparticles l...
Recent advances in understanding biological systems have proven that RNA is not merely the carrier o...
Human serum albumin nanoparticles (HSA-NPs) are widely-used drug delivery systems with applications ...
Serum albumin (SA) is the most abundant protein in plasma and represents the main carrier of endogen...
This study investigated the interaction between Human Serum Albumin (HSA) and microRNA 155 (miR-155)...
© The Royal Society of Chemistry. Gene therapy through systemic administration is expected to offer ...
Serum albumin (SA) is the most abundant protein in plasma and represents the main carrier of endogen...
Gene regulation through small interfering RNA (siRNA) is a useful way to improve therapeutics and tr...
In recent years, cancer has become an ever-growing issue in the eyes of the public and with such att...
The development of nucleic acid therapeutics has been hampered by issues associated with their stabi...
Small interfering RNA (siRNA) is receiving increasing attention with regard to the treatment of many...
The development of nonviral gene delivery systems is a great challenge to enable safe gene therapy. ...
Cancer is one of the major health problems worldwide, and hence, suitable therapies with enhanced ef...
For systemic siRNA delivery applications, well-defined drug carriers are required that guarantee sta...
Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, Arun Kulamarva, Satya PrakashBiomedical Technology ...
In this article, we address the design of innovative human serum albumin (HSA)-based nanoparticles l...
Recent advances in understanding biological systems have proven that RNA is not merely the carrier o...
Human serum albumin nanoparticles (HSA-NPs) are widely-used drug delivery systems with applications ...
Serum albumin (SA) is the most abundant protein in plasma and represents the main carrier of endogen...
This study investigated the interaction between Human Serum Albumin (HSA) and microRNA 155 (miR-155)...
© The Royal Society of Chemistry. Gene therapy through systemic administration is expected to offer ...
Serum albumin (SA) is the most abundant protein in plasma and represents the main carrier of endogen...